Clinical TrialID 7889

Agaricus Bisporus and Influenza Vaccination Response

NCT06041867

Immune Response

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7889
Evidence Id
7889
Core Evidence Id
7889
Source Clinical Trial Id
7887
Herb2 Clinical Trial Id
HBCT007887
Nct Id
NCT06041867
Title
Agaricus Bisporus and Influenza Vaccination Response
Status
Recruiting
Phase
Study Result
No
Study Condition
Immune Response
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Intervention
BIOLOGICAL: Influenza vaccine|DIETARY_SUPPLEMENT: Agaricus bisporus capsules|DIETARY_SUPPLEMENT: Control capsules
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
105
Outcome Measure
Vaccine specific antibody titer, The response to the Influenza vaccine will be measured by quantifying the specific antibody titer, Time Frame: Differences in influenza specific antibody titers at any measured time point ((Day=0 (day before vaccination), weekly in the month after vaccination (week 1, week 2, week 3 and week 4 after vaccination))
Sponsor Collaborator
Maastricht University Medical Center|Scelta Mycofriends B.V.|CNC Grondstoffen B.V.
Funded By
OTHER
Location
Maastricht University Medical Center, Maastricht, Limburg, 6229 ER, Netherlands
Other Id
METC 23-026
Start Date
2023-09-14
Primary Completion Date
2024-03-22
Completion Date
2024-05-30
First Posted
2023-09-18
Results First Posted
Last Update Posted
2024-03-01
Study Document
Study Url
https://clinicaltrials.gov/study/NCT06041867
Title Cn
Title En
Agaricus Bisporus and Influenza Vaccination Response
Bilingual Status
semi_complete